(Q31017251)

28 June 2017

title

Regulation of human cbfa1 gene transcription in osteoblasts by selective estrogen receptor modulators (SERMs). (English)

1 reference

28 June 2017

0 references

Tou L

1

1 reference

28 June 2017

Quibria N

series ordinal

2

1 reference

28 June 2017

Alexander JM

series ordinal

3

1 reference

28 June 2017

publication date

1 October 2001

1 reference

Molecular and Cellular Endocrinology

28 June 2017

published in

1 reference

28 June 2017

volume

183

1 reference

28 June 2017

issue

1-2

1 reference

28 June 2017

page(s)

71-79

1 reference

A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells

28 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Interaction of steroid hormone receptors with transcription factors involves chromatin remodelling

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Genetic control of cell differentiation in the skeleton

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

The developmental control of osteoblast-specific gene expression: role of specific transcription factors and the extracellular matrix environment

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Activation of the ovalbumin gene by the estrogen receptor involves the fos-jun complex

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Genomic organization, expression of the human CBFA1 gene, and evidence for an alternative splicing event affecting protein function

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Nuclear receptor coactivators and corepressors

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Collagenase 3 is a target of Cbfa1, a transcription factor of the runt gene family involved in bone formation

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Identification and functional characterization of a Smad binding element (SBE) in the JunB promoter that acts as a transforming growth factor-beta, activin, and bone morphogenetic protein-inducible enhancer

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Cbfa1 in bone development

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Targeted disruption of Cbfa1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Selective estrogen receptor modulators: a look ahead

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Mutations involving the transcription factor CBFA1 cause cleidocranial dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

PEBP2/PEA2 represents a family of transcription factors homologous to the products of the Drosophila runt gene and the human AML1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Selective estrogen receptor modulators: structure, function, and clinical use.

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Cbfa1, a candidate gene for cleidocranial dysplasia syndrome, is essential for osteoblast differentiation and bone development

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Parathyroid hormone regulates the rat collagenase-3 promoter in osteoblastic cells through the cooperative interaction of the activator protein-1 site and the runt domain binding sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

The osteoblast-specific transcription factor Cbfa1 contributes to the expression of osteoprotegerin, a potent inhibitor of osteoclast differentiation and function

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Tamoxifen activation of the estrogen receptor/AP-1 pathway: potential origin for the cell-specific estrogen-like effects of antiestrogens

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

Genomic structure and isoform expression of the mouse, rat and human Cbfa1/Osf2 transcription factor

1 reference

https://api.crossref.org/works/10.1016%2FS0303-7207%2801%2900594-9

7 January 2021

10.1016/S0303-7207(01)00594-9

Identifiers

DOI

1 reference

28 June 2017

1 reference